PT1161562E - Sequências deletadas em m. bovis bcg/m. bovis ou m. tuberculosis, processo de detecção das micobactérias utilizando as referidas sequências e vacinas - Google Patents

Sequências deletadas em m. bovis bcg/m. bovis ou m. tuberculosis, processo de detecção das micobactérias utilizando as referidas sequências e vacinas Download PDF

Info

Publication number
PT1161562E
PT1161562E PT00910960T PT00910960T PT1161562E PT 1161562 E PT1161562 E PT 1161562E PT 00910960 T PT00910960 T PT 00910960T PT 00910960 T PT00910960 T PT 00910960T PT 1161562 E PT1161562 E PT 1161562E
Authority
PT
Portugal
Prior art keywords
sequences
bovis
tuberculosis
vaccines
bcg
Prior art date
Application number
PT00910960T
Other languages
English (en)
Inventor
Stewart Cole
Stephen Gordon
Roland Buchrieser-Brosch
Alain Billault
Thierry Garnier
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of PT1161562E publication Critical patent/PT1161562E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT00910960T 1999-03-16 2000-03-16 Sequências deletadas em m. bovis bcg/m. bovis ou m. tuberculosis, processo de detecção das micobactérias utilizando as referidas sequências e vacinas PT1161562E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9903250A FR2791067B1 (fr) 1999-03-16 1999-03-16 Sequence deletees chez m.bovis bcg/m.ou m.tuberculosis, procede de detection des mycobacteries utilisant ces sequences et vaccins

Publications (1)

Publication Number Publication Date
PT1161562E true PT1161562E (pt) 2009-07-03

Family

ID=9543261

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00910960T PT1161562E (pt) 1999-03-16 2000-03-16 Sequências deletadas em m. bovis bcg/m. bovis ou m. tuberculosis, processo de detecção das micobactérias utilizando as referidas sequências e vacinas

Country Status (12)

Country Link
US (2) US8357493B2 (pt)
EP (1) EP1161562B9 (pt)
AT (1) ATE432360T1 (pt)
AU (1) AU3298900A (pt)
CA (1) CA2368088C (pt)
CY (1) CY1109210T1 (pt)
DE (1) DE60042268D1 (pt)
DK (1) DK1161562T3 (pt)
ES (1) ES2326358T3 (pt)
FR (1) FR2791067B1 (pt)
PT (1) PT1161562E (pt)
WO (1) WO2000055362A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1338657B9 (en) * 2002-02-25 2007-10-10 Institut Pasteur Sequences specifcally deleted from Mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
US20050058663A1 (en) * 2003-09-17 2005-03-17 Monif Gilles R. G. Mycobacterium avium subspecies paratuberculosis oral vaccine and methods
DK1922415T3 (en) 2005-09-05 2014-03-10 Bio Rad Innovations USE OF BOTH RD9 AND IS6110 AS nucleic acid targets FOR DIAGNOSIS OF TUBERCULOSIS, AND PROVISION OF MULTIPLEX-SUITABLE IS6110 AND RD9 TARGETS
EP3360566B1 (en) 2009-11-20 2019-12-25 Oregon Health&Science University Methods for detecting a mycobacterium tuberculosis infection
US9128098B2 (en) 2012-10-31 2015-09-08 Gilles R. G. Monif Fuidi herd management and risk stratification methods
GB201314873D0 (en) * 2013-08-20 2013-10-02 Univ Cape Town Method for diagnosing tuberculosis in a urine sample
CN108949783B (zh) * 2017-05-19 2021-03-26 复旦大学 一种重组卡介苗及其应用
WO2019135567A1 (en) * 2018-01-05 2019-07-11 Seegene, Inc. . Method for determining the presence or absence of m. tuberculosis, m. bovis and m. bovis bcg in a sample
CN110129465B (zh) * 2019-05-22 2023-08-22 杭州优思达生物技术股份有限公司 一种海分枝杆菌核酸的快速检测方法及其试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656493A (en) * 1985-03-28 1997-08-12 The Perkin-Elmer Corporation System for automated performance of the polymerase chain reaction
FR2663033B1 (fr) * 1990-06-08 1992-09-04 Pasteur Institut Detection specifique du mycobacterium tuberculosis.
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
WO1997029212A1 (en) 1996-02-08 1997-08-14 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
US6183957B1 (en) 1998-04-16 2001-02-06 Institut Pasteur Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria
US6294328B1 (en) * 1998-06-24 2001-09-25 The Institute For Genomic Research DNA sequences for strain analysis in Mycobacterium tuberculosis
US6291190B1 (en) * 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex

Also Published As

Publication number Publication date
CA2368088C (fr) 2012-08-07
US8357493B2 (en) 2013-01-22
DK1161562T3 (da) 2009-06-29
EP1161562B9 (fr) 2011-09-28
FR2791067B1 (fr) 2003-01-31
US20050250120A1 (en) 2005-11-10
DE60042268D1 (de) 2009-07-09
WO2000055362A1 (fr) 2000-09-21
CY1109210T1 (el) 2014-07-02
EP1161562B1 (fr) 2009-05-27
ES2326358T3 (es) 2009-10-08
EP1161562A1 (fr) 2001-12-12
US20130164749A1 (en) 2013-06-27
ATE432360T1 (de) 2009-06-15
CA2368088A1 (fr) 2000-09-21
FR2791067A1 (fr) 2000-09-22
AU3298900A (en) 2000-10-04

Similar Documents

Publication Publication Date Title
CY1109210T1 (el) Διαγραφεισες αλληλουχιες στο μ. bovis bcg/m. bovis ΄η μ. tuberculosis, μεθοδος ανιχνευσεως μυκοβακτηριων που χρησιμοποιουν αυτες τις αλληλουχιες και εμβολια
Kaufmann et al. Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64‐kDa protein
CA2316975A1 (en) Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
CY1109652T1 (el) Lawsonia intracellularis ευρωπαϊκης προελευσεως και εμβολια, διαγνωστικοι παραγοντες και μεθοδοι χρησεως τους
WO2001062893A3 (en) Compounds and methods for diagnosis and immunotherapy of tuberculosis
WO2002033116A3 (en) Nucleic acid ligands to the prostate specific membrane antigen
WO2003049762A3 (en) Immunisation against chlamydia trachomatis
AU5394699A (en) Molecular differences between species of the (m. tuberculosis) complex
AU4078599A (en) Expression vectors for stimulating an immune response and methods of using the same
EP1032417A4 (en) BACTERIAL VACCINES, CONTAINING AUXOTROPHIC DELAYED LISTERIA STRAINS, WHICH HETEROLOGIST EXPRESS ANTIGENS
NO174630C (no) Fremgangsmåte ved fremstilling av en vaksine mot streptokokkinfeksjoner
CY1106584T1 (el) Αλληλουχιες που εξαλειφονται ειδικα απο το γονιδιωμα του μυκοβακτηριου της φυματιωσης (mycobacterium tuberculosis ) και η χρηση τους στη διαγνωστικη και σαν εμβολια
CY1107950T1 (el) Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι
EP1220925B8 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2004102199A3 (en) Method for selecting and producing vaccine components and vaccines based thereon
WO2004083448A3 (en) Molecular differences between species of the m.tuberculosis complex
WO2002044406A3 (en) Projection against mycobacterial infections
YU22202A (sh) Vakcina
FI971402A (fi) Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä sisältävien rokotteiden valmistamiseksi
Dow et al. Immunization with f-Met peptides induces immune reactivity against Mycobacterium tuberculosis
IL149415A0 (en) Adjuvanted genetic vaccines
DE60031106D1 (de) Fluordesoxyuridin-resistente streptococcus gordonii stämme
Blaser et al. Antisera against a Peb1 antigen from campylobacter jejuni